VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2019 | Cellular and targeted therapies for Hodgkin lymphoma

Pauline Brice
EBMT 2019
Hodgkin Lymphoma Lymphoma Brentuximab vedotin Checkpoint inhibitors

Here, Pauline Brice, MD, PhD, of Hopital Saint-Louis, Paris, France, talks about the new targeted and cellular therapies for Hodgkin lymphoma. Dr Brice was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

More from Pauline Brice

1:13
Treatment combinations in Hodgkin lymphoma
Pauline Brice

Related Videos

1:41
Key challenges of using the intestinal microbiome as a biomarker
Melody Smith
1:32
CAR T-cell therapy: the importance of LTFU
Graham Collins
2:55
CD19 CAR T-cell therapy for lymphoma
Michael Schmitt
1:23
Axicabtagene ciloleucel in the real-world: safety and efficacy
David Maloney
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals